Petersenn, S. et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat. Rev. Endocrinol. 19, 722–740 (2023).
Song, Z. J. et al. The genome-wide mutational landscape of pituitary adenomas. Cell Res. 26, 1255–1259 (2016).
Article CAS PubMed PubMed Central Google Scholar
Neou, M. et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37, 123–134.e5 (2020).
Article CAS PubMed Google Scholar
Zhang, F. et al. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors. Cell Res. 32, 1047–1067 (2022).
Article CAS PubMed PubMed Central Google Scholar
Li, C. et al. Somatic SF3B1 hotspot mutation in prolactinomas. Nat. Commun. 11, 2506 (2020).
Article CAS PubMed PubMed Central Google Scholar
Simon, J. et al. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours. Eur. J. Endocrinol. 189, 372–378 (2023).
Duhamel, C. et al. Immunotherapy in corticotroph and lactotroph aggressive tumors and carcinomas: two case reports and a review of the literature. J. Pers. Med. 10, 88 (2020).
Article PubMed PubMed Central Google Scholar
Tang, H. et al. Case report: temozolomide treatment of refractory prolactinoma resistant to dopamine agonists. Front. Endocrinol. (Lausanne) 12, 616339 (2021).
Raverot, G. et al. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur. J. Endocrinol. 178, G1–G24 (2018).
留言 (0)